SMO and mesothelioma: SMO and GLI1 gene expression levels, tumor site, patient's gender, and history of asbestos exposure were all risk factors for survival time in mesothelioma patients (P < 0.05), and the findings were consistent with greater significance for the prognostic value of mesothelioma.